https://investor.ironwoodpharma.com/press-releases/press-release-details/2015/Ironwood-Reports-Positive-Top-Line-Results-from-Phase-III-Trial-of-72-mcg-Linaclotide-in-Adults-with-Chronic-Idiopathic-Constipation/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- October 13, 2015